Alector Competitors and Similar CompaniesClear all
Alector's competitors and similar companies include ACADIA Pharmaceuticals, Verge Genomics, Encoded Therapeutics, NKGen Biotech, Quince Therapeutics and C2N Diagnostics.
 Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Verge Genomics Verge Genomics is a biopharmaceutical company using systems biology to accelerate the development of treatments for neurodegenerative diseases. |  Encoded Therapeutics Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. |  NKGen Biotech NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells. |  Quince Therapeutics Quince Therapeutics (formerly known as Cortexyme) is a biopharmaceutical company developing therapeutics for Alzheimer's disease and other degenerative disorders. |  C2N Diagnostics C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. | |
Founding Date | Founding Date 2013 | Founding Date 1993 | Founding Date 2015 | Founding Date 2014 | Founding Date 2017 | Founding Date 2012 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||||
Locations | Locations San Francisco, US HQ | Locations San Diego, US HQ Princeton, US | Locations South San Francisco, US HQ | Locations South San Francisco, US HQ | Locations Santa Ana, US HQ | Locations San Francisco, US HQ | Locations St. Louis, US HQ |
Employees | Employees 2382% decrease | Employees 513 | Employees 57 | Employees 1651% decrease | Employees 7316% increase | Employees 2321% increase | Employees 96 |
Valuation ($) | Valuation ($) 495.3 m | Valuation ($) 2.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11 m | Valuation ($) 51.1 m | Valuation ($) N/A |
Financial | |||||||
Revenue (est.) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($142.9m) (FY, 2025) | Net income $391m (FY, 2025) | Net income N/A | Net income N/A | Net income ($44.3m) (FY, 2024) | Net income ($84m) (FY, 2025) | Net income N/A |
Funding | |||||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 32m (almost 8 years ago) | Latest funding round $ 135m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 20m (almost 6 years ago) |
Total funding raised | Total funding raised $ 194.5m | Total funding raised $ 770.8m | Total funding raised $ 36.1m | Total funding raised $ 239.1m | Total funding raised $ 11m | Total funding raised $ 100m | Total funding raised $ 20m |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companyVerge Genomics
HQ
South San Francisco, US
Employees
57
Verge Genomics is a biopharmaceutical company using systems biology to accelerate the development of treatments for neurodegenerative diseases.
View companyEncoded Therapeutics
HQ
South San Francisco, US
Employees
165↓ 1% decrease
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders.
View companyNKGen Biotech
HQ
Santa Ana, US
Employees
73↑ 16% increase
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
View company